Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05851313
What this trial is testing

Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response

Who this might be right for
COVID-19 Respiratory Infection
Sulaimani Polytechnic University 500
Not applicableLooking for participantsNCT04706390
What this trial is testing

Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination

Who this might be right for
Covid19
University of Bergen 2,500
Testing effectiveness (Phase 2)Study completedNCT04429854
What this trial is testing

Donated Antibodies Working Against nCoV

Who this might be right for
COVID-19
Universitaire Ziekenhuizen KU Leuven 483
Not applicableStudy completedNCT04673279
What this trial is testing

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Who this might be right for
Coronavirus Disease 2019
Hospital Italiano de Buenos Aires 189
Not applicableStudy completedNCT04779424
What this trial is testing

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)

Who this might be right for
SARS-CoV-2COVID-19
Universiteit Antwerpen 3,390
Not applicableUnknownNCT05664919
What this trial is testing

Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 7,000
Not applicableUnknownNCT05172167
What this trial is testing

Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra

Who this might be right for
COVID-19
Universidad de Antioquia 200
Testing effectiveness (Phase 2)WithdrawnNCT04770467
What this trial is testing

A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19

Who this might be right for
COVID-19
Brii Biosciences, Inc.
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Not applicableStudy completedNCT04355533
What this trial is testing

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

Who this might be right for
COVID-19 Infection
Assistance Publique - Hôpitaux de Paris 1,056
Early research (Phase 1)Not Yet RecruitingNCT07156864
What this trial is testing

"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 35
Early research (Phase 1)Ended earlyNCT05429021
What this trial is testing

IMM-BCP-01 in Mild to Moderate COVID-19

Who this might be right for
SARS-CoV2 InfectionCOVID-19
Immunome, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT04524507
What this trial is testing

Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients

Who this might be right for
COVID-19
University of North Carolina, Chapel Hill 56
Not applicableStudy completedNCT04597047
What this trial is testing

Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test

Who this might be right for
Covid19
LumiraDx UK Limited 42
Early research (Phase 1)UnknownNCT06048393
What this trial is testing

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 80
Not applicableStudy completedNCT04483622
What this trial is testing

Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients

Who this might be right for
Covid19
Sohag University 33
Not applicableStudy completedNCT04498286
What this trial is testing

COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Zoé van Kempen 546
Not applicableUnknownNCT05162456
What this trial is testing

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation

Who this might be right for
SARS-CoV2 InfectionSARS-CoV2 Antibodies
Collegium Medicum w Bydgoszczy 250
Large-scale testing (Phase 3)Ended earlyNCT05074433
What this trial is testing

Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults

Who this might be right for
Immunocompromised
Regeneron Pharmaceuticals 66
Not applicableStudy completedNCT04490837
What this trial is testing

Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID)

Who this might be right for
Covid-19
Corporacion Parc Tauli 3,500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation